Is IQV Stock Still the Best Pick Among Its Peers?
Here is how IQV stacks up against its peers in size, valuation, growth and margin.
- IQV’s operating margin of 14.7% is decent, and lower than most peers – trailing MTD (28.7%).
- IQV’s revenue growth of 2.8% in the last 12 months is low, outpacing MTD, TMO, WAT, BIO but lagging MEDP.
- IQV’s stock is down 15.9% in last 1 year, and trades at a PE of 26.4; it underperformed MTD, MEDP, WAT, BIO.
| IQV | MTD | TMO | MEDP | WAT | BIO | |
|---|---|---|---|---|---|---|
| Market Cap ($ Bil) | 35.3 | 26.3 | 179.6 | 13.8 | 17.6 | 7.3 |
| Revenue ($ Bil) | 15.5 | 3.8 | 42.9 | 2.2 | 3.0 | 2.5 |
| PE Ratio | 26.4 | 31.0 | 27.6 | 33.3 | 26.7 | -3.4 |
| LTM Revenue Growth | 2.8% | 1.2% | 1.0% | 9.9% | 2.6% | -2.5% |
| LTM Operating Margin | 14.7% | 28.7% | 18.3% | 21.2% | 28.3% | 9.8% |
| LTM FCF Margin | 14.0% | 22.7% | 15.7% | 25.1% | 20.8% | 13.1% |
| 12M Market Return | -15.9% | -8.9% | -17.1% | 19.3% | -2.2% | -15.4% |
While peer comparison is critical Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risks while giving upside exposure.
Revenue Growth Comparison
| LTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| IQV | 2.8% | 2.8% | 4.0% | 3.9% |
| MTD | 1.2% | 2.2% | -3.4% | 5.4% |
| TMO | 1.0% | 0.1% | -4.6% | 14.5% |
| MEDP | 9.9% | 11.8% | 29.2% | 27.8% |
| WAT | 2.6% | 0.1% | -0.5% | 6.7% |
| BIO | -2.5% | -3.9% | -4.7% | -4.1% |
Operating Margin Comparison
Relevant Articles
| LTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| IQV | 14.7% | 14.7% | 13.8% | 12.7% |
| MTD | 28.7% | 29.1% | 28.5% | 28.7% |
| TMO | 18.3% | 18.0% | 17.1% | 18.9% |
| MEDP | 21.2% | 21.2% | 17.9% | 19.1% |
| WAT | 28.3% | 28.3% | 27.7% | 29.7% |
| BIO | 9.8% | 10.5% | 12.6% | 17.0% |
PE Ratio Comparison
| LTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| IQV | 20.8 | 25.9 | 31.3 | 35.2 |
| MTD | 29.0 | 30.1 | 33.6 | 37.3 |
| TMO | 28.9 | 31.4 | 34.2 | 31.1 |
| MEDP | 22.9 | 25.4 | 33.3 | 28.0 |
| WAT | 33.3 | 34.5 | 30.3 | 29.0 |
| BIO | -3.1 | -5.0 | -14.8 | -3.5 |
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.